These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33306258)

  • 1. Evaluation of a framework for safe and appropriate prescribing of psychoactive medications in a UK prison.
    Bebbington E; Lawson J; Nafees S; Robinson C; Poole R
    Crim Behav Ment Health; 2021 Apr; 31(2):131-142. PubMed ID: 33306258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and appropriateness of psychotropic medication prescribing in a nationally representative cross-sectional survey of male and female prisoners in England.
    Hassan L; Senior J; Webb RT; Frisher M; Tully MP; While D; Shaw JJ
    BMC Psychiatry; 2016 Oct; 16(1):346. PubMed ID: 27724879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Keeping a lid on it': Exploring 'problematisations' of prescribed medication in prisons in the UK.
    Duke K; Trebilcock J
    Int J Drug Policy; 2022 Feb; 100():103515. PubMed ID: 34798433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence and predictors of psychoactive substance use among men in prisons].
    Caravaca-Sánchez F; Falcón Romero M; Luna A
    Gac Sanit; 2015; 29(5):358-63. PubMed ID: 26228003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring prison buprenorphine misuse in the United Kingdom: a qualitative study of former prisoners.
    Tompkins CN; Wright NM; Waterman MG; Sheard L
    Int J Prison Health; 2009; 5(2):71-87. PubMed ID: 25759139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for substitution treatments in prison populations].
    Michel L; Maguet O
    Encephale; 2005; 31(1 Pt 1):92-7. PubMed ID: 15971645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term condition management for prisoners: improving the processes between community and prison.
    Wright N; Hankins F; Hearty P
    BMC Fam Pract; 2021 Apr; 22(1):80. PubMed ID: 33902449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of mental disorder in remand prisoners: consecutive case study.
    Birmingham L; Mason D; Grubin D
    BMJ; 1996 Dec; 313(7071):1521-4. PubMed ID: 8978227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants.
    Soni A; Walters P
    Int J Prison Health; 2019 Aug; 16(1):67-77. PubMed ID: 32040271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
    Ralphs R; Williams L; Askew R; Norton A
    Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Producing the 'problem' of new psychoactive substances (NPS) in English prisons.
    Duke K
    Int J Drug Policy; 2020 Jun; 80():102479. PubMed ID: 31155432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond equivalence of care in prison pharmacy.
    Choudhry K; Evans N
    Int J Pharm Pract; 2014 Oct; 22(5):363-5. PubMed ID: 24400788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consumption of psychoactive substances in prison: Between initiation and improvement, what trajectories occur after incarceration? COSMOS study data.
    Rousselet M; Guerlais M; Caillet P; Le Geay B; Mauillon D; Serre P; Chameau PY; Bleher Y; Mounsande S; Jolliet P; Victorri-Vigneau C
    PLoS One; 2019; 14(12):e0225189. PubMed ID: 31800580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Psychoactive Substances and Violence within a UK Prison Setting.
    Mason R; Smith M; Onwuegbusi T; Roberts A
    Subst Use Misuse; 2022; 57(14):2146-2150. PubMed ID: 36269768
    [No Abstract]   [Full Text] [Related]  

  • 15. Dementia-friendly prisons: a mixed-methods evaluation of the application of dementia-friendly community principles to two prisons in England.
    Treacy S; Haggith A; Wickramasinghe ND; Van Bortel T
    BMJ Open; 2019 Aug; 9(8):e030087. PubMed ID: 31399461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring substance misuse in a prison in Wales: a cross-sectional analysis.
    Gray BJ; Craddock C; Couzens Z; Lines R; Perrett SE
    Lancet; 2023 Nov; 402 Suppl 1():S46. PubMed ID: 37997088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication prescribing practices for older prisoners in the Texas prison system.
    Williams BA; Baillargeon JG; Lindquist K; Walter LC; Covinsky KE; Whitson HE; Steinman MA
    Am J Public Health; 2010 Apr; 100(4):756-61. PubMed ID: 19762661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug and alcohol use and treatment for Australian Indigenous and non-Indigenous prisoners: demand reduction strategies.
    Dolan K; Rodas A; Bode A
    Int J Prison Health; 2015; 11(1):30-8. PubMed ID: 25751705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the challenges to safer prescribing and medication monitoring in prisons: A qualitative study with health care staff.
    Magola-Makina E; Abuzour AS; Ashcroft DM; Dunlop J; Brown P; Keers RN
    PLoS One; 2022; 17(11):e0275907. PubMed ID: 36327312
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.